These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 12711862)

  • 21. Antibodies against oxidized LDL and apolipoprotein E polymorphism in demented patients.
    Bednarska-Makaruk M; Rodo M; Graban A; Lojkowska W; Bochyńska A; Ryglewicz D; Wehr H
    J Neurol Sci; 2009 Aug; 283(1-2):137-8. PubMed ID: 19303604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The composition, structural properties and binding of very-low-density and low-density lipoproteins to the LDL receptor in normo- and hypertriglyceridemia: relation to the apolipoprotein E phenotype.
    Dergunov AD; Novoselov AV; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biol Chem; 2005 May; 386(5):441-52. PubMed ID: 15927888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of lipoprotein cholesterol and triglycerides with the severity of coronary artery disease in men and women.
    Korhonen T; Savolainen MJ; Koistinen MJ; Ikäheimo M; Linnaluoto MK; Kervinen K; Kesäniemi YA
    Atherosclerosis; 1996 Dec; 127(2):213-20. PubMed ID: 9125311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating oxidized low density lipoprotein, autoantibodies against them and homocysteine serum levels in diagnosis and estimation of severity of coronary artery disease.
    Faviou E; Vourli G; Nounopoulos C; Zachari A; Dionyssiou-Asteriou A
    Free Radic Res; 2005 Apr; 39(4):419-29. PubMed ID: 16028367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.
    Xu RX; Zhang Y; Li XL; Li S; Guo YL; Dong Q; Liu G; Li JJ
    Clin Chim Acta; 2015 Jun; 446():195-200. PubMed ID: 25934512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of apo E phenotype on plasma postprandial triglyceride levels in young male adults with and without a familial history of myocardial infarction: the EARS II study. European Atherosclerosis Research Study.
    Dallongeville J; Tiret L; Visvikis S; O'Reilly DS; Saava M; Tsitouris G; Rosseneu M; DeBacker G; Humphries SE; Beisiegel U
    Atherosclerosis; 1999 Aug; 145(2):381-8. PubMed ID: 10488967
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increases in dietary cholesterol and fat raise levels of apoprotein E-containing lipoproteins in the plasma of man.
    Cole TG; Patsch W; Kuisk I; Gonen B; Schonfeld G
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1108-15. PubMed ID: 6841553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of apolipoprotein E polymorphism on serum lipid, lipoproteins, and atherosclerosis in hemodialysis patients.
    Güz G; Nurhan Ozdemir F; Sezer S; Işiklar I; Arat Z; Turan M; Haberal M
    Am J Kidney Dis; 2000 Oct; 36(4):826-36. PubMed ID: 11007687
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The apolipoprotein CI content of triglyceride-rich lipoproteins independently predicts early atherosclerosis in healthy middle-aged men.
    Hamsten A; Silveira A; Boquist S; Tang R; Bond MG; de Faire U; Björkegren J
    J Am Coll Cardiol; 2005 Apr; 45(7):1013-7. PubMed ID: 15808756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Higher level of plasma cholesteryl ester transfer activity from high-density lipoprotein to apo B-containing lipoproteins in subjects with angiographically detectable coronary artery disease.
    Hibino T; Sakuma N; Sato T
    Clin Cardiol; 1996 Jun; 19(6):483-6. PubMed ID: 8790953
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of apolipoprotein E polymorphism on serum lipid and lipoprotein changes: a 21-year follow-up study from childhood to adulthood. The Cardiovascular Risk in Young Finns Study.
    Grönroos P; Raitakari OT; Kähönen M; Hutri-Kähönen N; Marniemi J; Viikari J; Lehtimäki T
    Clin Chem Lab Med; 2007; 45(5):592-8. PubMed ID: 17484618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LDL size distribution in relation to insulin sensitivity and lipoprotein pattern in young and healthy subjects.
    Ambrosch A; Mühlen I; Kopf D; Augustin W; Dierkes J; König W; Luley C; Lehnert H
    Diabetes Care; 1998 Dec; 21(12):2077-84. PubMed ID: 9839097
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regional differences in apolipoprotein E polymorphism in Finland.
    Lehtimäki T; Moilanen T; Nikkari T; Solakivi T; Porkka K; Ehnholm C; Rönnemaa T; Akerblom HK; Uhari M; Nuutinen EM
    Ann Med; 1991 Feb; 23(1):61-6. PubMed ID: 2036207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Associations of apolipoprotein E polymorphism with low-density lipoprotein size and subfraction profiles in Arab patients with coronary heart disease.
    Akanji AO; Suresh CG; Fatania HR; Al-Radwan R; Zubaid M
    Metabolism; 2007 Apr; 56(4):484-90. PubMed ID: 17379005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interactions between age and apoE genotype on fasting and postprandial triglycerides levels.
    Carvalho-Wells AL; Jackson KG; Gill R; Olano-Martin E; Lovegrove JA; Williams CM; Minihane AM
    Atherosclerosis; 2010 Oct; 212(2):481-7. PubMed ID: 20643407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study.
    Tani S; Yagi T; Atsumi W; Kawauchi K; Matsuo R; Hirayama A
    Cardiovasc Diabetol; 2017 Oct; 16(1):123. PubMed ID: 28969633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Smaller low-density lipoprotein size as a possible risk factor for the prevalence of coronary artery diseases in haemodialysis patients: associations of cholesteryl ester transfer protein and the hepatic lipase gene polymorphism with low-density lipoprotein size.
    Kimura H; Miyazaki R; Imura T; Masunaga S; Shimada A; Mikami D; Kasuno K; Takahashi N; Hirano T; Yoshida H
    Nephrology (Carlton); 2011 Aug; 16(6):558-66. PubMed ID: 21352420
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum lipoproteins and apolipoprotein E in infants with congenital hypothyroidism.
    Ciomartan T; Asami T; Uchiyama M
    Pediatr Int; 1999 Jun; 41(3):249-52. PubMed ID: 10365572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New evidence from plasma ceramides links apoE polymorphism to greater risk of coronary artery disease in Finnish adults.
    Karjalainen JP; Mononen N; Hutri-Kähönen N; Lehtimäki M; Hilvo M; Kauhanen D; Juonala M; Viikari J; Kähönen M; Raitakari O; Laaksonen R; Lehtimäki T
    J Lipid Res; 2019 Sep; 60(9):1622-1629. PubMed ID: 31270131
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Apolipoprotein E phenotype affects the malondialdehyde-modified LDL concentration and forearm endothelial function in postmenopausal women.
    Tsuda M; Sanada M; Higashi Y; Hara Y; Kodama I; Chayama K; Yoshizumi M; Ohama K
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):619-25. PubMed ID: 15521966
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.